The Valdosta Daily Times7d
Electromed, Inc. Announces Share Repurchase Authorization
NEW PRAGUE, Minn.-- (BUSINESS WIRE)--Sep 11, 2024-- ...
Business Insider1d
Vivos Therapeutics Gets FDA 510(k) Clearance To Treat Pediatric Sleep Apnea, Snoring; Stock Up
and a 40% increase in airway volumes. The company stated that this marks what is believed to be the first clearance for an oral medical device targeting pediatric OSA treatment. In pre-market activity ...
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Awarded First-Ever FDA Clearance for Pediatric Treatment of Sleep Apnea, Snoring
Vivos Therapeutics (NASDAQ: VVOS), a leading medical-device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related ...
Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring
Vivos is poised to disrupt the very significant pediatric obstructive sleep apnea (OSA) market with new FDA clearance and new strategic marketing ...